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Particle Size Characterization- Techniques, 
Factors and Quality-by-design Approach 




Particle size and size characterization knowledge act as a prereq- 
uisite for all the processes which are involved in the production 
of a formulation. They influence mechanical strength, electri- 
cal and thermal properties of the finished product. Massive pro- 
duction losses can occur if particle sizes of the materials being 
used in the process are not appropriately monitored [1]. A wide 
range of materials starting from proteins and polymers, micro- 
emulsions, viruses, droplets, pigments up to sand and cement re- 
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is about describing particle sizes in a formulation that helps in 
understanding, predicting and optimizing pharmacokinetic prop- 
erties of that formulation. Accurate determination of particle size 
is necessary for pharmaceutical industry. It is a physical param- 
eter that must be specified, examined and managed right from 
the starting material to the finished product. Despite the modern 
instrumentation, there are some challenges faced in the field of 
particle size characterization- 
Need for an appropriate method development specific to drug 
type, form, and delivery. The very minute quantity of sample 
available, especially, in initial stages of drug development. 
Inaccuracies in data interpretation due to most of the particles 






Particle size characterization is one of the key areas involved in quality assurance. The concept of particle size and size char- 
acterization acts as a foundation for all the processes involved in the production of a formulation; from manufacturing to quality 
control operations. Particle size characterization dictates many properties of the finished product. Particle size characterization 
of samples is important to make a better quality product, improve its appearance, taste, texture and shelf-life. There are many 
instruments for particle size characterization that are available commercially. Each instrument is based on a different technique 
and each technique is based on a different principle. Selecting the right particle size characterization technique for the given 
sample is a challenging decision. The choice of technique is made according to the sample. Sometimes even a combination of 
techniques is used to obtain accurate results. There are several factors upon which choice of technique depends like size range, 
sample quantity, cost-effectiveness etc. To ensure appropriate quality standards in the field of particle sizing and particle size 
characterization, ICH and US-FDA have recently insisted on including Quality-by-design approach in the pharmaceutical indus- 
try. Application of QBD approach to particle size characterization techniques ensures a resilient method which gives reproducible 
results. It aids in reducing result and method variations and promotes productivity and quality. The main objectives of this review 
are first, to understand the principle, instrumentation, and working of commercially used techniques and to compare their pros 
and cons; secondly, to study the factors which govern the choice of technique and lastly, to understand the concept of Quality by 
design and its role in particle size characterization through some example. 
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Problems occurring during analytical measurements like ag- 
glomeration or de-stabilization [3]. 
For efficient particle size characterization, it is important to 
understand the instrumentation first. It is advised to use more 
than one technique to obtain accurate results. The main objec- 
tives of the present review are first, to understand the particle 
size characterization techniques commercially used, by compar- 
ing their pros and cons, secondly, to study the application of 
Quality-by-design approach to particle size characterization and 




The main purpose of particle size characterization in the phar- 
maceutical industry is to collect quantitative data on mean parti- 
cle size, particle size distribution, and particle shape. The other 
purpose is to ensure the quality of the finished drug product. 
This applies to powders, suspensions, emulsions, and aerosols. 
Flow and compaction properties of the powders are influenced 
by particle size and particle shape. Smaller particles have better 
dissolution profile and spherical particles have better flowabil- 
ity [4]. Aerosols with droplets having an aerodynamic diameter 
of 2-5 micrometers will penetrate deeper into the lungs [3]. Par- 
ticle size also greatly affects physicochemical and bio pharma- 
ceutical properties of drug materials and final dosage forms like 
absorption, dissolution, bio availability, flow properties of the 
drug. For example, micronization of drugs like chlorampheni- 
col, griseofulvin results in better absorption profile. But reduced 
particle size in case of lipophilic drugs like aspirin increases 
their effective surface area, thereby, decreasing their absorption 
manifolds. Particle size characterization in the powders ensures 
powder bed with appropriate and uniform particle size. It im- 
proves flow properties of the powder particles. Moreover, proper 
size characterization of drug materials helps in detecting con- 
tamination. Particle size characterization techniques can detect 
any deviations from the anticipated particle size range and hence 
confirm the presence of an impurity. For these reasons, particle 
size characterization is an important parameter in quality control 




Particle size characterization can be done using various com- 
mercially available instruments. Different instruments are based 
on different techniques, sometimes even a combination of tech- 
niques. Generally, the sample to be introduced into the instru- 
ment is first dispersed in an appropriate medium. The dispersion 
can be either wet or dry. Wet dispersion involves changing the 
solid-air interface into a solid-liquid one, that is, the sample is 
first dispersed in a liquid medium. Then, agitation and mixing 
are done to break down the agglomerates. Lastly, the disper- 
sion is stabilized by adding suitable surfactants. On the other 
hand, dry dispersion involves particles dispersed in dry form. 
Agglomerates in dry dispersion are broken by sheer and me- 
chanical forces. For efficient separation, air is passed through 
the sample before its introduction into the instrument. There are 
many factors which are considered before choosing one of the 
two dispersions. For example, the solubility of the sample in wa- 
ter, agglomeration tendency, solvent compatibility, hygroscopic- 
ity, fragility and toxicity of the material [6]. 
 
Techniques of particle size characterization/ analysis 
Laser diffraction technique 
This technique can be more appropriately called Low Angle 
Laser Light Scattering (LALLS). This is now a preferred method 
for particle size characterization and quality control in many in- 
dustries. According to ISO 13320, the particle size range where 
this technique is applicable is 0.1-3000 µm [7]. Laser diffrac- 
tion technique by static light scattering is based upon Mie the- 
ory of light scattering which also includes Fraunhofer theory. 
According to Mie theory, the intensity vs angle relationship ob- 
tained from scattering of laser light, is related to sizes of the 
particles participating in scattering, with other variables kept 
constant. The variables include the wavelength of the incident 
laser light and relative refractive index of sample and disper- 
sion medium [8]. The technique is based on the interaction be- 
tween light and particle surface. Laser diffraction analyses par- 
ticle sizes by determining angular variation in light intensity as 
the laser beam passes through a given sample. Bigger particles 
scatter light at smaller angles and smaller particles at wider an- 
gles [9]. Many particles together form a pattern of scattered light 
which can be converted into a particle size distribution curve. 
Utilizing Mie theory of light scattering, the particle size is mea- 
sured as Volume-weighted distribution. This method is based on 
the fact that diffraction angle is inversely proportional to parti- 
cle size [4]. The Fraunhofer approximation gives the following 
information- 
Wavelength of light used is much smaller than particle 
All particles disperse light with equal magnitude There is 
no penetration of light 
The optical model employed in Fraunhofer approximation states 
that particles are assumed – 
To be spherical 
To be non-transparent and impenetrable 
To scatter light equally at wide and narrow angles 
2
Dhamoon et al. International Journal of Drug Delivery.2018;10(1):01-11 
 
 
To communicate differently with light as compared to 
medium [9]. The above-given model restricts the choice of 
Fraunhofer ap- proximation for particle size characterization. 
But Mie theory of light scattering fulfills these drawbacks. It 
states that- 
The particle is assumed to be spherical 
The particle is present in homogeneous dispersion Refractive 
indices of both particle and medium are known [4]. 
Instrumentation  
Optical bench- It is where laser beam strikes the particles. 
Laser source commonly employed is a He-Ne gas laser as they 
are temperature-stable and have a better signal-to- noise ratio 
[7]. Detectors are also present to analyze the intensity of light 
scattered by particles. Photosensitive silicon with a series of 
detectors is generally used [9]. There is always an optimum 
number of detectors which can be used, like 16-32. Increasing 
the numbers does not lead to a better resolution [7]. 
Sample dispersion units- These units analyze the samples in 
their dry or wet dispersions. They guarantee that the sample 
reaches the optical bench at an optimum concentration. Wet dis- 
persion of sample requires a liquid vehicle- aqueous or organic 
solvent whereas dry dispersions require only dry air as a disper- 
sant. Instrument software- This consists of data controlling sys- 
tem which converts the pattern of scattered light into a readable 
particle size distribution curve. 
Advantages 
It has broad particle size analysis range. 
It offers flexibility in sample presentation. 
The whole of the sample can be analyzed and recovery is also 
possible. 
The technique is fast and gives reproducible and reliable 
results. 
There is no need for calibration in this technique, though 
validation is required. 
This technique does a direct measurement of dry powders. 
Laser diffraction is flexible in operations [3, 7, 10]. 
Disadvantages 
This technique is comparatively low in resolution. 
In this technique, particles with different optical properties 
cannot be analyzed. 
This technique is not for strongly absorbing materials. 
The validity of results depends upon the validity of data 
collected. 
There is high obscuration due to the high concentration of 
particles analyzed. 
There is over-estimation of volume diameter for non- 
spherical particles. 
Prior knowledge of refractive index is required. 
In this technique, the equivalent diameter is calculated which 
is not directly related to particle volume. 
Formulation ingredients may affect the data in this tech- nique 
[3, 10]. 
This method is mainly applied to low concentration samples 
to minimize multiple random scattering of the laser beam as 
oth- erwise, particle size distribution data would be so difficult 
to in- terpret [9]. For the particles with a size below one 
micron, the refractive index of sample material and dispersion 
fluid are re- quired to make Mie theory algorithmic 
corrections [11]. 
 
Dynamic Light Scattering 
Dynamic light scattering (DLS) is also known as Photon Cor- 
relation Spectroscopy (PCS) or Quasi-elastic Light Scattering 
(QELS). It measures particles in the range of 0.3nm-8µm.[10] 
Apart from measuring particle size, this technique also mea- 
sures zeta potential and molecular weight [12]. The basic 
prin- ciple involved is that Brownian motion of particles in a 
sus- pension causes scattering of the laser beam at different 
intensi- ties. These fluctuations correspond to velocity of 
Brownian mo- tion and therefore, particle size can be 
determined using Stokes- Einstein equation- 
kB T 
3πnD 
   Where, 
Dh: hydrodynamic diameter; Dt: translational diffusion coef- 
ficient; KB: Boltzmann’s constant; T: thermodynamic 
tempera- ture; n: dynamic viscosity [9]. 
When a monochromatic beam of light strikes a suspension 
containing the particles, the light gets scattered and spreads 
out in all directions. The particles in a suspension undergo 
Brownian motion. This motion causes changes in the distances 
between the particles and therefore, causes fluctuations in the 
phase of scat- tered light. So, the net result comes out to be 
fluctuating scattered intensity [13]. The larger the particle, the 
slower the Brownian motion. It is also used for measuring 
zeta potential of a parti- cle or estimating the molecular 
weight of organic compounds. The laser light strikes the 
sample in the cell and the scattered light is captured by 
detectors, either at 90◦ (a right angle) or 173◦(back angle). 
The signal can be deciphered by auto corre- lation function 
[4]. The particle size is measured in terms of hy- drodynamic 
diameter, which is the diameter of a sphere which has same 
translational diffusion coefficient as the particle [12]. 
Dh 
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It is an automatic image capturing technique in which individual 
particle pictures are captured from their dispersions and are an- 
alyzed for their respective sizes, shapes or other properties. This 
technique is of 2 types- 
Static automated imaging- in which the sample is kept sta- 
tionary, as on a microscopic slide, 
Dynamic automated imaging- in which the sample is in mo- 
tion, as in flow through the cell [4]. 
It is a high-resolution technique and measures particle size in 
the range of 1µ to millimeters. 
Instrumentation  1.  Sample  preparation  and  presentation- 
The sample is presented in the form of a dispersion with 2 
techniques- static or dynamic. In static imaging, the sample     
is poured on a microscopic slide, a glass plate or filter mem- 
brane and then viewed whereas, in case of dynamic imaging, a 
flow-through cell apparatus is employed. 
2. Imaging apparatus- a digital CCD camera is employed with 
desired magnification to capture 2D images of sample particles 
in the dispersion. Sample illumination is more flexible in case 
of static imaging as the sample is stationary and a number of 
techniques can be applied. On the other hand, the sample is es- 
sentially illuminated from behind in case of dynamic imaging 
as the particles are in motion and can only be illuminated from 
behind. 
Data recording and interpretation- Shape and size of each par- 
ticle are recorded, generally in the form of graphs and curves for 
















It employs a digital camera which clicks 2D images of sam- ple 
particles in the dispersion. Then particle distribution data is 
generated to report the results [4, 9]. 
This technique has an upper hand over other techniques as it 
can measure shape along with particle size. Particle shape mea- 
surement is important as it- 
Gives idea about whether the particle under consideration is a 
bigger particle or an agglomerate 
Shape reflects physical properties of a particle so it can be 
altered if required 
Helps in modifying the particle so as to improve powder flow 
[14]. 
Electron Stream Sensing Zone Technique (Coulter 
Counter Method) 
This technique was primarily invented by Wallace H. Coulter 
of United States Navy, to count blood cells. Its original model 
measured alterations in electrical conductance as each blood cell 
dispersed in an electrolyte solution, made way through an ori- 
fice. This original blueprint of the technique is known as the 
‘Coulter Principle’. This is a high-resolution particle size char- 
acterization technique as every single particle passing through 
the orifice is counted and measured [15]. In this, the particles  
to be measured for their respective size have to be dispersed    
in an electrolyte solution. An electrolyte solution is preferred  
as electrical conductivity is required. Any organic liquid with 
good electrical conductivity can also be used. The particles are 
dispersed in this electrolyte solution in low concentration. After 
that, the particles, essentially one-by-one, make passage through 


































Figure 3 Advantages and disadvantages of Automated imaging 
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insulator tube called the aperture tube. Electric current is ap- 
plied across this aperture, thereby, creating an electrical sensing 
zone. When a particle enters this aperture, it displaces a vol- 
ume of electrolyte equal to its own volume. This results in the 
generation of an electrical impulse for a short duration. In this 
apparatus, two electrodes are employed; one inside the aperture 
tube and another one outside. This creates a pathway for elec- 
trical conductance whenever an external electric field is applied. 
The alterations in the current are detected, often measured as 
impedance. From this method, particle volume is obtained, from 
which spherical diameter can be calculated and hence particle 
size distribution data can be generated. The particle size range 
for this technique is 0.2µm to 1600µm. If there are a variety of 
particles to be characterized, then two apertures instead of a sin- 
gle one are employed [16]. 
V: terminal velocity of particle; G: acceleration due to grav- 
ity; ρ: density of medium ; ρ: density of the particle; d: diameter 
of the particle; 6 : viscosity of medium 
So, if we know the time taken by the particle to travel a known 
distance, then its velocity can be easily determined by dividing 
distance traveled by time. Finally, when velocity is known, the 
diameter of the particle can be easily determined. 
The other theory of X-ray absorption aids in the determina- 
tion of particle concentration. The X-ray absorption technique 
is based on Beer-Lambert law which states that when an x-ray 
beam passes through a given sample, its intensity reduces and 
this reduction in intensity is directly dependent on the concen- 
tration of the sample. Alternatively, x-ray intensity decrement is 
directly proportional to the mass concentration of the sample. 
Beer-Lambert law has following expression- 
T I = e ∈ lc I◦ 
Where, 
T: Transmittance; I: Final intensity of x-radiation; I: Initial 
intensity; ε: Molar extinction coefficient; l: thickness of the 
medium; C: concentration of the sample in solution 
The value of the intensity of x-radiation is maximum with    a 
clear solution and minimum with homogeneously dispersed 
particles. So during the process of sedimentation, x-ray intensity 
rises from minimum to maximum. 
X- Ray Sedimentation 
The X-ray sedimentation technique has garnered a lot of atten- 
tion and found a bunch of applications since its manifestation  
in 1967 [17, 18]. This technique is primarily grounded on two 
theories- the sedimentation theory and the X-ray absorption the- 
ory. The analytical equipment which works on this principle is 
called Sedi Graph [18]. 
 
Theory  
The SediGraph works mainly on two principles. The first 
principle is the Sedimentation theory which is governed by 
Stokes’law. It states that when a particle homogeneously dis- 
persed in a liquid experiences gravitational force which gets 
equally balanced by buoyant and drags force, then it achieves   
a velocity called terminal velocity. This velocity depends upon 
size (diameter) and density of the particle. So alternatively, it can 
be quoted that the terminal (settling) velocity is directly propor- 
tional to a particle size of the drug. The equation for Stokes’ law 




In the SediGraph method, a homogeneous dispersion is 
prepared of particles under consideration in a suitable liq-  uid 
medium. Agitation is done to achieve this. Then agitation  is 
halted and all the particles are given time to settle down under 
gravity. The bigger particles settle first and smaller in the last. 
Each particle settles down with its own terminal velocity which 
is determined by taking the ratio of distance traveled by particle 
below a measurement zone to the time taken to cover this dis- 
tance. When velocity is calculated, the diameter of the particle 
can be easily calculated from the equation of Stokes’ law. Simul- 
taneously, as the particles settle down in the medium, the inten- 
sity of x-ray beam passing through medium also increases. This 
is because there is no hindrance in the path as the solution above 
is clear. This increment in intensity relationship with the con- 




It gives reproducible results. 
It allows usage of different liquid mediums. 
A small quantity of sample is required. 
Size determination is direct in this technique [19, 20]. 








Figure 4 Advantages and disadvantages of Coulter-Counter 
techniques 
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There are issues of sedimentation instability in this tech- 
nique. 
Frequent deviation from Stokes’law  is  also a  chal- lenge 
[19, 20]. 
Selecting an appropriate particle size characterization technique 
out of all the available options is a challenging task. There are 
several techniques to choose from and also, significant attention 
to be paid to technique- to- technique variations. The notion that 
one particular technique is suitable for all the tasks is not a true 
one [21]. The variations may come because of differences in dy- 
namic range, algorithmic or mechanical improvements in the in- 
struments. Switching from older techniques like sieving to ad- 
vanced ones like laser diffraction can also be the cause of varia- 
tions. Data generated from sieving is comparatively smaller than 
that obtained by laser diffraction. Microscopic and image anal- 
ysis techniques are best suited when particle shape is the main 
area of interest. In case of dispersions and suspensions, when 
particle size, as well as zeta potential, are the areas of inter-  
est, then Dynamic Light Scattering technique is the method of 
choice [22]. 
 
Factors to consider while selecting a particle size 
analyzer 
Abundant particle size characterizations exist from old (sieving, 
sedimentation) to new (laser diffraction, dynamic light scatter- 
ing). Selecting the most appropriate technique for characteriza- 
tion depends upon a number of variables. Some are listed below- 
Understanding the existing analytical technique- This in- 
volves understanding the working and limitations of the tech- 
nique. The company can reject a technique because they do not 
find its resolution up to the mark. Sometimes, a technique is em- 
ployed because the literature backs its usefulness. Sometimes, 
the company aspires to establish a correlation in the results, so 
they use the same technique which was used earlier in the same 
experiment. 
Size range- The choice of analyzer strongly depends upon the 
size range to be detected and analyzed. Different analyzers 
work on different size ranges. It is considered wise to select the 
instrument with the particle size range which encompasses the 
desired size in its middle. 
Material to be analyzed- The technique to be chosen also de- 
pends upon the nature of the material to be analyzed. Like what 
type of material it is- free-flowing, dry powder, dry or wet dis- 
persion, suspension or emulsion. For example, a material prone 
to agglomeration or a highly water-soluble material can be best 
analyzed in the form of dry powder by Static Light Scattering 
Technique. 
Appropriate throughput- This refers to the efficiency of the 
whole measurement process. Analysts often consider throughput 
to be an indication of how fast a technique can produce a result 
with precision. The faster and precise the technique, the faster 
the analyst would know about the lapses in the experiment and 
the areas which need improvement. Laser diffraction is the best 
technique when it comes to fast analysis and throughput. 
The quantity of sample- The choice of the technique also de- 
pends upon the amount of sample available for analysis. Smaller 
the amount, more efficient the instrument and hence more diffi- 
culties with managing cost and cleaning. In practice, with very 
small volumes of sample, dynamic light scattering is preferred 
and with relatively larger particle sizes, laser diffraction or im- 
age analysis is considered. 
Cost-effectiveness- There is always conflict in industries when 
it comes to cost-effectiveness and efficiency. More effi- ciency 
and accuracy calls for a higher budget. That is where the need 
to find a balance between these two arise. In many cases, high 
initial costs reduce long time costs. For example, the instru- 
ment with highly technical and modern software will produce 
more accurate results and automatic nature will reduce the need 
for an operator and operator-related errors. Hence, there will be 
less investment in procedure corrections and error rectification. 
So, budget management is a daunting task which calls for good 
analytical skills [22]. 
 
Particle Size Characterization in Formulations 
A wide range of particle sizes exists for particles used in the 
formulations in the form of active pharmaceutical ingredient 
and excipients such as in dry powders, suspensions, semisolid 
dispersions. Such particles size range from nanometers (in ad- 
vanced formulations) to millimeters (in granules). A variety of 
properties of a dosage form depends upon their particles sizes 
and shapes like- 
Rate of drug dissolution and the amount of drug bio avail- able 
Release kinetics of the drug 
Pharmacokinetic parameters, especially of novel formula- tions 
Uniformity of the dose and stability of formulation 
Rheological properties of the formulations, like flow abil- ity, 
mixing etc [3]. 
Some of the formulations along with their respective particle 
sizes and instrumentation are listed in table 2- [23–29]. 
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Quality By Design Approach In Particle Size 
Characterization 
The concept of quality by design (QBD) was first put forth by 
Dr. Joseph M. Juran who believed that quality should be instilled 
into a product from the very beginning as the breaches in qual- 
ity arise from the way with which the product was developed  
in the first place [30]. Quality by design as per ICH document 
Q8(R2)(ICH Q8) can be explained as an “organized approach to 
an establishment having its foundation with already laid goals, 
focuses on product and process understanding, based on scien- 
tific ground and quality risk management” [31]. Pharmaceutical 
QBD is a systematic, scientific, risk-based and holistic approach 
that works as per pre-laid objectives to ensure quality in a prod- 
uct. QBD identifies the critical quality attributes which are crit- 
ical to the quality of a product. It also decides when and how 
the process attributes should be varied so as to ensure maximum 
quality product [32]. 
The US-FDA also encourages inculcation of QBD principles in 
the development of drug product [30]. For QBD approach   in 
particle size characterization, it will be more appropriate to 
quote it as ‘Analytical QBD’(AQBD) as particle size characteri- 
zation comes under analytical method development. Application 
of quality by design (QBD) to the desired particle size character- 
ization technique guarantees a resilient method as well as assists 
in obtaining a quality product (in this case quality particle size) 
with reproducible results. The AQBD approach generally con- 
sists of six steps. These steps are explained by quoting Laser 
Diffraction as an example of Particle size Characterization tech- 
nique. The adoption of QBD principles in the pharmaceutical in- 
dustry has resulted in reduced variability within manufacturing 
process and hence an enhanced productivity and professional- 
ism. Moreover, QBD approach has an upper hand over Standard 
Operating Procedures (SOPs) as the former is more flexible and 
can be adjusted to obtain desired results whereas the latter is 
quite rigid [31]. 
Step 1: Analytical Target Profile (ATP) 
This is the very first step in Analytical QBD. This can be ex- 
plained as laying down or defining method goals as to what ex- 
actly we expect from a method to do. ATP helps in laying down 
goals of the analytical method development process to achieve 
Quality Target Product Profile (QTPP) [33]. For example, we 
know that particle size directly affects dissolution and bio avail- 
ability of a drug so particle size characterization is the goal that 
we should work towards achieving optimum product quality. 
This ensures reproducibility and accuracy of results. To identify 
the ATP for a particle characterization technique, it is important 
to consider the reason why we require particle size measurement 
or analysis, like what exactly do we need that can be achieved 
from a particle size characterization technique. Is it enhanced 
solubility or is it improved flow properties. This is called de- 
ciding method goals or developing ATP. Moreover, not only de- 
sired characteristics but also accuracy and repeatability of results 
are to be considered in developing ATP. This requires consider- 
ation of an appropriate particle size characterization which will 
give accurate results in the desired range of particle size. For in- 
stance, laser diffraction gives most accurate results in the micron 
range [31]. 
 
Step 2: Identify Critical Method Attributes (CMAs) 
Once a technique is finalized in the process of ATP, the Analyt- 
ical QBD approach now looks into identifying critical method 
attributes (CMAs) which may pose a potential risk in achiev- 
ing desired result and accuracy. CMAs include processes or pa- 
rameters associated with particle size characterization technique 
which may affect results. In case of laser diffraction, the poten- 
tial error sources are a dispersion, sampling, and instrumenta- 
tion. Out of these three, dispersion and sampling pose a greater 
threat to the accuracy of results. As far as sampling is concerned, 
it mainly depends upon measurement time of analytical method. 
It decides how much sample is collected and how much is ana- 
lyzed. On the other hand, when it comes to dispersion, it is good 
to consider the reason for particle size characterization again. If 
flow ability is to be checked, then analysis in agglomerated form 
is suggested. If their individual characteristics are to be studied, 
like solubility or bio availability, then analysis in original parti- 
cle size is recommended, as in dispersion. For example, dry and 
wet dispersion are the two ways a sample can be presented for 
analysis in laser diffraction technique. 
 
Step 3: Risk Assessment 
The outlined risk in laser diffraction that can cause variation in 
results came out to be dispersion. The risk assessment involves 
assessing and analyzing the outlined risk. This involves consid- 












Figure 5 Objectives of Pharmaceutical quality-by-design 
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Laser Diffraction 0.1-3000µm Particle size -Mie theory of light 
scattering 
-Fraunhofer theory 





0.3mm-8µm -Particle size; 
-Zeta potential 
-Molecular weight 











Image capturing Dispersion Yes 
Electron stream 
sensing zone 
0.2-1600µm -Particle size 
-Particle charge 






0.1-300µm Particle size -Sediment-ation theory 







Table 2 Particle size characterization of different formulations 
 
S. Formulation Particle Technique Instrument used Use of the formulation  
no. or carrier size used   
1 Niosomes 0.85-1.01 Laser Mastersizer X version 2.15, Malvern Instruments, To enhance ribavirin liver [23] 
  µm diffraction Malvern, U.K concentration for liver targeting  
2 Liposomes 110-135 Dynamic light Particle size NICOMP 380 Submicron particle For efficient delivery of Epirubicin [24] 
  nm scattering analyzer, Particle sizing system, CA, U.S.A   
3 Nanoparti- 186-107 Laser Malvern-Zetasizer Tumor targeting by enhancing [25] 
 cles nm diffraction 3000hs, Malvern, UK concentration of doxorubicin  
4 Dendrimers 534-373 Dynamic light Malvern For efficient liver cancer drug [26] 
  nm scattering Nanosizer, ZN series, Malvern Instruments Ltd, delivery and sustained kinetics  
    Malvern,   
    UK   
5 Micro- 24.30 to Microscopic AXIOPALN To enhance mucoadhesion and [27] 
 spheres 52.40 µm image analysis microscope better targeting  
6 Microcap- 100-1000 Laser Mastersizer 2000z, model Hydro 2000MU optimization of spray-drying [28] 
 sules µm diffraction (Malvern process conditions  
    Instruments, Malvern, UK   
7 Ethosomes    1.112 0. 053µ Dmynamic light 
scattering 
Malvern Zetamaster ZEM 5002, 
Malvern, UK 






various processes involved which can contribute to variability. 
Some of such considerations for wet dispersion are- a) the em- 
ployment of a suitable liquid as a dispersant which can make 
the technique more challenging, b) even smallest of particle- 
liquid interaction can induce variation in results and affect re- 
producibility of laser diffraction, c) some drugs are not compati- 
ble with water, the most commonly preferred dispersant because 
of its non- reactivity, low cost and accessibility. On the other 
hand, the wet dispersion is the preferred choice for friable and 
breakable samples which cannot be analyzed dry. Also, the wet 
dispersion is used at times when contact of drug particles with 
the environment has to be cut. All of such considerations make 
up risk assessment and the areas which require attention, are 
outlined. Some designs of risk assessment as mentioned in ICH 
guideline Q9 is Failure Mode Effects Analysis (FMEA), Failure 
Mode, Effects and Criticality Analysis (FMECA) etc. These fur- 
ther assist in identification of Critical Process Parameters (CPPs) 
which can impact the quality of final product [34]. 
 
Step 4: Method Operable Design Region (MODR) 
Once the risks are assessed, they are systematically studied and 
a design is created which will give reproducible results and meet 
target profile goals [31]. The risk assessment and MODR are 
based upon studies conducted with the help of Fish bone di- 
agram (Ishikawa diagram), Failure Mode and Effects Analysis 
(FMEA) and a risk prioritization matrix. These are regarded as 
risk assessment tools [35]. The design region describes the re- 
lationship between process parameters and critical quality at- 
tributes [34]. Ishikawa diagram was first introduced by Kaoru 
Ishikawa in 1968. It is commonly called as Wishbone diagram 
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because of its resemblance to a fish’s skeleton. The main pur- 
pose of Wishbone diagram is to prevent quality breaches and to 
identify and expose the underlying factors which can be poten- 
tial threats to the quality of a product [36]. The general head- 
ing included in a Wishbone diagram are- methods, machines, 
personnel, material, measurement, and environment. Taking wet 
dispersion as an example, areas which can cause variation are- 
sonication time, sample quantity, agitation power and measure- 
ment time. Similarly, a Wishbone diagram for dry dispersion can 
also be made. Areas requiring attention, in that case, would be 
air pressure and feed rate. In Failure Module and Effects Analy- 
sis (FMEA), each variable shortlisted in Wishbone diagram can 
be studied in detail. Failure modes mean the routes by which 
some methods can fail and effect analysis means assessing what 
could be the ramifications of such a failure [37]. Each variable 
is assigned a number from 1 to 10 based on 3 factors- severity, 
probability, and detection. The Risk Priority Number (RPN) is 
then calculated as follows with each factor having to rate from 1 
to 5- 
Severity × P robability × Detection 
Greater the RPN, greater will be the failure effects and hence 
greater variability. [38]. The goal of FMEA is to identify the ar- 
eas requiring attention and doing extra experiments to establish 
their significance in product quality. Now all the outlined fac- 
tors or variables are analyzed with the help of risk prioritization 
matrix. The variables which receive the highest ratings are then 
grouped into two categories. For example, in Laser diffraction, 
factors affecting particle size and factors affecting the measure- 
ment. Then separate two designs of the experiment are drafted 
for these groups. The DoE approach offers two privileges- first, 
it upgrades the efficiency of data compilation and secondly, cuts 
down a number of experiments to be done, thereby, directly sav- 
ing cost also.[35]. 
Step 5: Control Strategy 
This is the last step in Analytical QbD. The concept of con-  
trol strategy was introduced by ICH Q8(R2)4 guideline. The 
ICH Q10 guideline describes control strategy as an organized 
set of controls which are obtained from the understanding of  
the current product and helps in maintaining product quality. It 
includes various controls like in-process testing, end- process 
testing. A control strategy can encompass any attributes affect- 
ing drug product, equipment, materials, methods etc. It helps in 
ensuring quality, safety, and efficacy of drug product. Control 
strategy focuses on the components which could have an impact 
on Critical Quality Attributes (CQAs). The control strategy is   
a way to demonstrate to the regulatory authorities how errors 
and variations are handled. [39]. Control strategy ensures qual- 
ity assurance and method validation. [31]. The control strategy 
includes method parameters that can cause variability and need 
to be overhauled [35]. Control strategy depends upon the nature 
of formulation to be characterized and MODR. Method control 
strategy can be manipulated based on the information obtained 
from Design of Experiment and MODR [31]. The main aim    
of control strategy and method validation is to ensure that the 
method is appropriate for use or ‘fit for purpose [31, 40]. Preset 
criteria can be standardized in the form of ATP. The ATP defines 
suitable performance indicator for the appropriate analytical re- 
sult. In a QbD, two points need to be well-defined, first, what 
analytical methods need to be employed and second, where do 
they need to be employed [40]. According to USP and FDA’s lat- 
est Guidance for Industry for Analytical Procedures and Method 
Validation, accuracy, precision and concentration range need to 
be assessed. The decision on concentration range depends upon 
the nature of analyte and type of method being validated. Apart 
from these three attributes, calibration, robustness, and repro- 
ducibility must also be assessed [31]. 
 
Conclusions 
It is usually recommended that a particular sample should be 
characterized by at least two different techniques to develop     a 
cross-correlation and obtain a better idea about the particle 
properties. Further development in the design and technology of 
particle size characterization instruments is anticipated in near 
future. The dispersion methods need to be revised and modi- 
fied. Newer and better computer software is required for better 
analysis of the compound and equivalent particle diameter cal- 
culations. Nowadays, scientists prefer to describe whole parti- 
cle size distribution range instead of just mentioning a single 
value. Sources of errors associated with instruments must be 
looked into and mentioned in the final specifications. Also, there 
is a need for acceptance of various particle size characterization 
techniques in Pharmacopoeias and Regulatory agencies, thereby, 













Figure 6  Steps in pharmaceutical quality-by-design 
9
Dhamoon et al. International Journal of Drug Delivery.2018;10(1):01-11 
 
References 
[1] Jillavenkatesa A, Dapkunas SJ, Lum L-SH.  practice 
guide Particle size caracterization, Nist. Special pu 
.2001;164. doi:Particle size characterization. 
[2] Informatics H. Course # Course #.2011;4–5. 
[3] Shekunov BY, Chattopadhyay P, Tong HHY, Chow 
AHL. Particle size analysis in pharmaceutics: Principles, 
methods and applications, Pharm. Res. 2007;24:203–227. 
doi:10.1007/s11095-006-9146-7. 
[4] Scientific H. a Guidebook To Particle Size Analysis, 
Distribution. 2010;1–17. 
[5] Brummer  H.   Particle   characterisation   in   excipi- 
ents, drug products and drug substances. Pharma 
Times.2010;42:24–26. 
[6] Choosing between wet and dry dispersion,(n.d.). 
[7] Rawle A. Basic principles of particle size analysis. 
1993;44:1-8. 
[8] Light L. Technique S, What can Micromeritics Analytical 
Services (MAS) do to help me?, Statistics (Ber).(n.d.) 1- 9. 
[9] Malvern Ltd. A basic guide to particle 
characterization.2015. http://www.malvern.com. 
[10] Europe CPSI. Comparison of Particle  Sizing  Meth-  
ods.Availablefrom://www.cpsinstruments.eu/pdf/Compar
e%20Sizing%20Methods.pdf. 31 (n.d.) 1–18. 
[11] David BF, Weiner.  A Guide to Determination of Par-  
ticle Size – Making an Effective and Reliable Measure- 
ment, Brookhaven Instruments. 2017;1:1–3. 
http://bic.com/pdf/theory/Determination of Particle 
Size.pdf. 
[12] Spectroscopy PC. Scattering  QL,  Motion B. Dynamic 
Light Scattering.(DLS) DLS Measurement – Scattered 
Light Intensity Fluctuation, Malvern Guid. (2011). 
[13] Malvern Instruments Ltd. Dynamic Light Scattering 
(DLS),Malvern.com.(n.d.).http://www.malvern.com/en/pr
oducts/technology/dynamic-light-scattering/. 
[14] Malvern Instruments Limited, Automated Imaging, 2017. 
http://www.malvern.com/de/products/product-
range/morphologi-range/morphologi-g3-id/default.aspx. 
[15] Behind the Coulter Principle,(n.d.). 
[16] Saleh OA, Sohn. LL, Introduction I, Coulter counter, Rev. 
Sci Instrum.2001;72:4449–4452 doi:10.1063/1.1419224. 
[17] Plain MP. Advantages and Disadvantages of Different Lax- 
atives.(n.d.)2-3. 
[18] Law B. The Sedi Graph Method of Particle Sizing. 
1877;42901. 
[19] Ceramic Industry, Sizing Particles with  X- 
Ray Sedimentation, 2004. 
http://www.ceramicindustry.com/articles/86703-sizing- 
particles-with-x-ray-sedimentation. 
[20] Laidlaw  I,  Steinmetz  M.   Introduction  to  Differen-   tial 
Sedimentation, Anal. Ultracentrifugation Tech 
Methods.2005;31:270–290. doi:10.1039/9781847552617-
00270. 
[21] Bruce B, Ph. BW. A Guide to Choosing a Particle Sizer ©, 
Brookhaven Instruments Corp. White Pap.(n.d.).1–9. 




[23] Nidhi K. Indrajeet S, Khushboo M, Gauri K, Sen DJ. Hy- 
drotropy: A promising tool for solubility enhancement: A 
review, Int. J Drug Dev Res;2011;3:26–33. 
doi:10.1002/jps. 
[24] Zhang T, Zhou S. Hu L, Peng B, Liu Y, Luo X, Song Y, Liu 
X, Deng Y. Polysialic acid-modifying liposomes for effi- 
cient delivery of epirubicin, in-vitro characterization and 
in-vivo evaluation, Int. J Pharm.2016;515:449–459. 
doi:10.1016/j.ijpharm.2016.10.051. 
[25] Yadav AK, Mishra P, Mishra AK, Mishra P, Jain S, 
Agrawal GP. Development and characterization of 
hyaluronic acid-anchored PLGA nanoparticulate carri-  
ers of doxorubicin, Nanomedicine Nanotechnology, Biol. 
Med.2007;3:246–257 doi:10.1016/j.nano.2007.09.004. 
[26] Nomani A. Haririan I, Rahimnia R, Fouladdel S, Gazori  
T, Dinarvand R, Omidi E, Azizi Y. Physicochemical and 
biological properties of self-assembled antisense / poly. J 
Nanomedicine.2010;–359-369. 
[27] Maddiboyina B. Asthana A, Asthana GS, Singh S, Ramya 
M, Sunnapu O, Kotla N. Formulation and characteriza- 
tion of polycarbophil coated mucoadhesive microspheres 
of repaglinide. J Pharm Sci Res.2015;7:972–977. 
[28] Baranauskaite J. Ivanauskas L, Masteikova R, Ko- 
pustinskiene D, Baranauskas A, Bernatoniene J. Formu- 
lation and characterization of Turkish oregano microcap- 
sules prepared by spray-drying technology, Pharm. Dev 
Technol.2016;7450:1–12.doi:10.1080/10837450. 
2016.1189934. 
[29] Barupal AK, Gupta V, Ramteke S. Preparation and Char- 
acterization of Ethosomes for Topical delivery of. Ace- 
clofenac, Indian J Pharm Sci.2010;72:582–586. 
doi:10.4103/0250-474X.78524 
[30] Yu LX, Amidon G, Khan MA, Hoag SW, Polli J, Raju 
GK, Woodcock J. Understanding Pharmaceutical Quality 
by Design. AAPS J. 2014;16:771–783. 
doi:10.1208/s12248-014-9598-3 
[31] Kippax AP, Manager GP. Beyond SOPs – Exploring the 
rigor and requirements of. Analytical QbD.2015;8:1-19. 
[32] Patil AS. Pethe AM. Quality by design (QbD): A new 
concept for development of quality pharmaceuticals, Int. J 




Dhamoon et al. International Journal of Drug Delivery.2018;10(1):01-11 
 
 
[33] Peraman R, Bhadraya K, Padmanabha Reddy Y. Analytical 
quality by design: A tool for regulatory flexibility and robust 
analytics, Int. J. Anal. Chem.  2015. doi:10.1155/2015/868727. 
[34] Patel M, Sawant K. A Quality by Design Concept on Lipid 
Based Nanoformulation Containing Antipsychotic Drug: 
Screening Design and Optimization using Response Sur-face 
Methodology. J Text Sci Eng;2017;8. doi:10.4172/2157-
7439.1000442. 
[35] Adamson JT. A Quality by Design Approach for Parti-  cle Size 
Analysis of an Active Pharmaceutical Ingredient. 2013. 
[36] Wikipedia, Ishikawa diagram, Wikipedia. 2013;1–4. 
http://en.wikipedia.org/w/index.php?oldid=575668016 
[37] Tague NR. Fishbone Diagram (Ishikawa) - Cause & Effect 
Diagram, Qual. Toolbox.2005:247–249. http://asq.org/learn-
about-quality/cause-analysis-tools/overview/fishbone.html 
[38] Quality Risk Management Application in Quality System.2011. 
[39] Piriou J. Elissondo B, Hertschuh M, Ollivier R. Control Strategy 
as the Keystone of the Product Lifecycle , from Product / 
Process Understanding to Continuous Process Verification and 
Improvement, Pharm. Eng.2012;32. 
[40] Chorghade MS. Pharma outsourcing, Chim. Oggi. 2003. 
11
